What researchers published on Diffuse large B-cell lymphoma
1,634 papers, newest first.
Showing 60 of 1,634
Case reportDiffuse Large B-Cell Lymphoma Presenting as Clinically Isolated Massive Splenic Disease: A Case Report.Cureus
Not labelled yetDynamic prognostic stratification and survival prediction in elderly patients with diffuse large B-cell lymphoma: a real-world evidence study.BMC cancer
Case reportIntermittent reduced-dose methotrexate enabled continuation of induction therapy despite severe delayed methotrexate elimination in primary central nervous system lymphoma: a case report.Journal of medical case reports
Review[Treatment strategies for lymphoma in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
Not labelled yetPatient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO.Clinical lymphoma, myeloma & leukemia
Not labelled yetTemporal clinical trajectories and Day+14 landmark stratification of infection risk after CD19 CAR T-cell therapy.Frontiers in cellular and infection microbiology
Not labelled yetDiffuse Large B-Cell Lymphoma Presenting as a Rapidly Enlarging Forehead Mass Initially Suggestive of a Subgaleal Hematoma: A Case Report.Clinical case reports
Case reportDiffuse Large B-cell Lymphoma With Tumor Thrombus in the Superior Mesenteric Vein: A Case Report.Cureus
Not labelled yetHypoxia-induced NETs establish a self-reinforcing immunosuppressive circuit that can be targeted to enhance immunotherapy in DLBCL.Journal of translational medicine
Not labelled yetCorrection: Deceptive initial presentation of systemic DLBCL with CNS progression following oligometabolic PET/CT: case report.Frontiers in oncology
Case reportPrimary Cervical Diffuse Large B-cell Lymphoma Incidentally Diagnosed During Evaluation of High-Grade Cervical Dysplasia: A Case Report.Cureus
Not labelled yetProjected population size by treatment line in diffuse large B-cell lymphoma in the United States, 2024-2028.Leukemia & lymphoma
Not labelled yetExpression profiles of long non-coding RNAs ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2 in diffuse large B-cell lymphoma: a case-control study focusing on GCB and non-GCB subtypes.BMC medical genomics
Not labelled yetCorrection: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study.Blood cancer journal
Case report[Cardiac Malignant Lymphoma with Right Atrial Occlusion Responding to Tumor Resection and Postoperative Chemotherapy:Report of a Case].Kyobu geka. The Japanese journal of thoracic surgery
Not labelled yetEfficacy and safety of orelabrutinib plus R-CDOP as first-line therapy in diffuse large B-cell lymphoma with high-risk CNS-IPI: a prospective, multicenter, single-arm, phase II study.Frontiers in oncology
Case reportLower Back Pain As the Initial Manifestation of Primary Follicular B-cell Non-Hodgkin Lymphoma of the Bone Marrow: A Case Report.Cureus
Not labelled yetGeneration and multidimensional profiling of a rituximab-resistant ABC-type diffuse large B-cell lymphoma cell line.Epigenomics
Not labelled yetThe cyclin-G associated kinase (GAK) is a clinically actionable drug target required for mitosis in diffuse large B-cell lymphoma.Leukemia
ReviewProgression-free survival prediction in diffuse large B-cell lymphoma: where can we further improve?Expert review of hematology
Not labelled yetBaseline Spleen Volume is Independently Associated With Survival After CD19-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.Hematological oncology
Case reportEpcoritamab achieves durable remission after CD20 antigen escape in primary cardiac diffuse large B-cell lymphoma.Annals of hematology
Review[Reappraisal of the value of CD30 testing in the diagnosis and treatment of lymphoma].Zhonghua bing li xue za zhi = Chinese journal of pathology
Not labelled yetCentral and peripheral Neurolymphomatosis, a rare involvement of DLBCL on PET/CT.EJNMMI reports
Not labelled yetA temporal coupling hypothesis for chemoresistance in canine DLBCL and osteosarcoma: stress signalling and microRNA regulation.Veterinary and animal science
Not labelled yetHu B, Reagan PM, Sehn LH, et al. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Adv. 2025;9(10):2489-2499.Blood advances
Case reportPrimary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type, With Rapid Systemic Progression in an Elderly Patient: A Case Report.Cureus
Not labelled yetEconomic evaluation of PET-CT in staging and response assessment of patients with diffuse large B-cell lymphoma (DLBCL) in Thailand: a cost-utility analysis.Cost effectiveness and resource allocation : C/E
Case reportWhen lymphoma masquerades as carcinoma: A rare case of primary nasopharyngeal diffuse large B-cell lymphoma with aberrant p63 expression.Indian journal of pathology & microbiology
Not labelled yetA Rare Case of Hypoglossal Nerve Neurolymphomatosis in a Patient Treated With Diffuse Large B-Cell Lymphoma.EJHaem
Not labelled yetPlasma metabolomics and ctDNA analysis in newly diagnosed diffuse large B-cell lymphoma: an exploratory study.Blood advances
Not labelled yetReal-world outcomes of glofitamab monotherapy in heavily pretreated patients with relapsed/refractory diffuse large B-cell lymphoma: A multicenter Korean cohort.Annals of hematology
Not labelled yetBeta-blocker use and survival in diffuse large B-cell lymphoma: a post hoc analysis of the RICOVER-60 trial.Haematologica
Not labelled yetSintilimab plus R-CHOP versus DA-EPOCH-R as first-line therapy for primary mediastinal large B-cell lymphoma: a real-world comparative cohort study.Frontiers in immunology
Not labelled yetPrimary Prostatic Diffuse Large B-Cell Lymphoma Mimicking Prostate Cancer With a Normal Prostate-Specific Antigen Level.IJU case reports
Not labelled yetDiffuse large B cell lymphoma in rheumatoid arthritis express polyreactive and autoreactive BCRs binding protein modifications.Arthritis research & therapy
ReviewRole of PET/CT in diffuse large B-cell lymphoma (Review).Molecular and clinical oncology
Not labelled yetAn Exploratory Study of Fusion of Intratumoral and Peritumoral Ultrasound Radiomics With Clinical Features for Distinguishing Diffuse Large B-Cell Lymphoma From Hodgkin Lymphoma.Ultrasound in medicine & biology
Review[Current treatment strategies for diffuse large B-cell lymphoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
Not labelled yetMIP-1α and MIP-1ß as Potential Contributors to Bone Lesion Formation in Diffuse Large B-cell Lymphoma: A Case Report.Internal medicine (Tokyo, Japan)
Case reportMyocardial Infarction with Non-obstructive Coronary Arteries; Diffuse Large B-Cell Lymphoma Presenting as an Acute Coronary Syndrome.Archives of academic emergency medicine
Case reportPrimary renal diffuse large B cell lymphoma misdiagnosed as renal cell carcinoma: A case report.Medicine
Not labelled yetDistinct clinical associations of baseline and treatment-emergent hypogammaglobulinemia in diffuse large B-cell lymphoma: a retrospective real-world cohort study.Annals of hematology
Not labelled yetPlasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.Biomedicines
Case reportPersistent Type B Hyperlactataemia as a Diagnostic Clue to Occult Diffuse Large B-cell Lymphoma-Associated Haemophagocytic Lymphohistiocytosis.Cureus
Case reportIntestinal Mature B-Cell Non-Hodgkin Lymphoma Presenting as an Acute Surgical Abdomen in Children: A Case Series.Pediatric reports
Randomised trialBaseline Tumor Transcriptional Features and Event-Free Survival After Anti-CD19 CAR T-Cell Therapy with Axicabtagene Ciloleucel in Large B-Cell Lymphoma: An Exploratory Reanalysis of the Randomized ZUMA-7 Trial.Medical sciences (Basel, Switzerland)
Case reportCD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy.Cureus
Case reportPlasmablastic non-Hodgkin's lymphoma: a case report and review of the literature.Journal of medical case reports
Not labelled yetPrediction of Double-Expressor Lymphoma in Diffuse Large B-Cell Lymphoma Using a Non-invasive Model Based on [18F] FDG PET/CT and Stacking.Academic radiology
Randomised trialZamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.The Lancet. Oncology
Case reportAnti-Transcriptional Intermediary Factor 1 Gamma Antibody-Positive Dermatomyositis Concomitant with Diffuse Large B-Cell Lymphoma: Case Report and Literature Review.Case reports in oncology
PreprintPOU2AF2/OCA-T1 coactivates POU2F2 and defines a lineage-specific dependency in diffuse large B-cell lymphoma.bioRxiv : the preprint server for biology
Not labelled yetIbrutinib and standard immunochemotherapy in younger, high-risk patients with diffuse large B-cell lymphoma: A phase II study of GLA.British journal of haematology
Not labelled yetAssociations of Subcutaneous and Visceral Fat Areas with Progression-Free Survival in Patients with Diffuse Large B-Cell Lymphoma.International journal of medical sciences
Not labelled yetA public-data audit of transcriptomic prognostic transportability in R-CHOP-treated diffuse large B-cell lymphoma.PloS one
Not labelled yetSecond Primary Malignancy in Patients with DLBCL Receiving CAR T Therapy and Other Systemic Anticancer Therapy: Real-World Evidence from a Large US National Claims Database.Transplantation and cellular therapy
Not labelled yetOutcomes of gastrointestinal bleeding events after first-line chemotherapy in gastrointestinal-diffuse large B-cell lymphoma: a propensity-score matched analysis.Annals of hematology
Not labelled yetBone marrow gene methylation detection for prognostic evaluation in diffuse large B-cell lymphoma.Leukemia research
Not labelled yetRacial and socioeconomic differences in time to treatment initiation and outcomes in aggressive non-Hodgkin lymphoma.Blood neoplasia